Florida-based wealth advisory J. L. Bainbridge & Co. sold 119,376 shares of Biogen (NASDAQ:BIIB) in the third quarter for approximately $16.1 million, as disclosed in a recent SEC filing. Following the sale, the firm now holds only 2,969 shares of Biogen, valued at $415,898, reducing Biogen’s stake to 0.03% of its reported U.S. equity assets as of September 30.
Want More Context? 🔎
Loading PerspectiveSplit analysis...
